全球移动心臟遥测系统市场：增长、未来展望、竞争分析（2022-2030 年）

全球移动心臟遥测系统市场正以 9.1% 的复合年增长率稳健增长。全世界成年人（主要是 55 岁及以上）的心脏病和心力衰竭的发病率和患病率正在增加，提高了患者的安全性，并增加了对先进和快速实时监测的需求。正在推动整个市场的增长.

按产品来看，以铅为基础的细分市场约占全球市场份额的 65%。由于移动心电图仪诊断性能的提高，基于贴片的先进遥测系统预计将受到患者更大的需求，预计 2022 年至 2030 年的复合年增长率将超过 9.0%（以货币计算）

按最终用户划分，医院部门占据了最大的市场份额。心血管疾病、心脏病和其他疾病导致的住院人数增加将推动市场增长。

2021 年，北美地区将占据最大的市场份额。主要在诊断领域，能够实时监测患者心电图的新型移动设备的批准将使其相关性达到前所未有的水平。

本报告分析了全球移动心臟遥测系统市场，包括市场基本结构、宏观和微观环境因素、整体市场规模趋势展望（2020-2030），我们彙编并提供详细趋势等信息按最终用户和地区划分，主要市场驱动因素和限制因素、主要参与者的概况和增长战略。

内容

第一章前言

第 2 章执行摘要

第 3 章移动心臟遥测系统市场：业务前景和市场动态

• 简介
• 全球移动心臟遥测系统市场规模（单位：百万美元，2020-2030）
• 市场动态
  • 市场驱动力
  • 市场製约因素
  • 主要问题
  • 主要机会
• 促进和抑制因素的影响分析
• 跷跷板分析
• 波特五力分析
• PESTEL 分析

第 4 章移动心臟遥测系统市场：按产品分类（单位：百万美元，2020-2030）

• 市场概览
• 增长和收益分析（2021/2030）
• 市场细分
  • 领导基地
  • 基于补丁

第 5 章移动心臟遥测系统市场：按最终用户分类（单位：百万美元，2020-2030 年）

• 市场概览
• 增长和收益分析（2021/2030）
• 市场细分
  • 医院
  • 医务室
  • 门诊手术中心

第 6 章北美移动心臟遥测系统市场（单位：百万美元，2020-2030）

• 市场概览
• 按产品分列的移动心臟遥测系统市场（单位：百万美元，2020-2030）
• 移动心臟遥测系统市场：按最终用户分类（单位：百万美元，2020-2030 年）
• 按地区分列的移动心臟遥测系统市场（单位：百万美元，2020-2030）
  • 北美

第 7 章。英国和欧盟国家的移动心臟遥测系统市场（单位：百万美元，2020-2030）

第 8 章亚太移动心臟遥测系统市场（单位：百万美元，2020-2030）

第 9 章拉丁美洲移动心臟遥测系统市场（单位：百万美元，2020-2030）

第 10 章中东和非洲移动心臟遥测系统市场（单位：百万美元，2020-2030）

第 11 章公司简介

• Medtronic Plc
• Medicomp Inc.
• BioTelemetry Inc.
• ZOLL Medical Corporation
• Welch Allyn
• ScottCare
• Siemens Healthcare Pvt. Ltd
• Biotricity Inc.
• Preventice Solutions
• Telerhythmics LLC.
• Applied Cardiac Systems Inc.
• Philips Benelux

"Mobile cardiac telemetry systems market to exhibit dynamic growth during the forecast period"

The global mobile cardiac telemetry systems market is mounting competently, growing at a healthier CAGR of 9.1%. Mobile cardiac telemetry systems are essentially used for remote monitoring in real time and transmission of cardiac measures to the doctors or physicians. These are mainly applied for disease indications such as cardiac arrhythmia, heart related conditions, atrial fibrillation, etc. Worldwide, growing incidences and prevalence for cardiac disorders, heart failure among the adult population (mainly above 55 years), and increasing need for advanced and quick real time monitoring of patients along with enhanced patient safety will drive the overall market growth.

"Lead based segment expected to capture a larger market share by 2030"

Advancement in lead based and patch based along with the development in the field of real time data monitoring will improve the overall growth globally. Increased focus on cardio activities and responses of the mobile devices will improve the general state of the cardiovascular diagnostics industry. The lead based segment represents around 65% of the market share globally. Improved diagnostic yield of the mobile cardiac devices expected to generate great demand from the patients. Advanced patch-based telemetry systems are expected to register a CAGR of more than 9.0% in terms of revenue from 2022 to 2030.

Furthermore, the increasing demand in the home care settings is gaining traction slowly owing to speedy expansion in the ageing population. Growing incidence of cardiovascular disorders expected to generate higher growth opportunities for the mobile cardiac system manufacturers in the near future. The global market generally suffers from a deficiency of diversity in products and concentrated price battles. Nevertheless, manufacturers can gain traction from an improved focus on ways of commercializing their brands globally and retaining cost-containment processes.

"Hospitals generated maximum revenue share in 2021"

Hospitals segment generated maximum market share in the global market. The utilization of lead based technology is high. Increased hospital admissions for cardiovascular diseases, heart conditions and other disorders will boost market growth. As of 2016, around 28 Mn individuals in the USA were diagnosed with heart disease. Russia has the highest prevalence heart related disease, with more than 1,750 heart disease-related deaths per 100,000 individuals. In 2016, more than 17.5 Mn people died from cardiovascular related diseases, representing around 30% of all worldwide deaths.

Advancement in bioengineered technology, FDA approval of new devices, increasing population with cardiac issues, and improved outcomes with real time monitoring will drive the overall market growth for mobile cardiac telemetry systems market. Increasing awareness and utilization of lead based systems in the hospitals and ASCs will show significant growth in the near future.

"Increasing adult population, launch of new mobile devices and the presence of top manufacturers holds the U.S. market in dominant position"

In 2021, the North America region accounted for maximum market share globally due to an upsurge in admissions for cardiac disorders, increasing rates for heart failure, atherosclerosis, angina pectoris and others. Approval of new mobile devices mainly in the diagnostics segment that include real time monitoring of a patient ECG, will have unprecedented levels of relevancy.

Presently, overall patient cardiac monitoring (on & off site) is rowing efficiently in the developed nations, prevalence and burden of chronic diseases will further spur revenue growth. However, real time accuracy, patient data security, less awareness and usage among the physicians in the emerging regions, high cost, and unstructured product penetration are few major factors restraining the market growth on a global scale.

"Increased research and development with strong product pipelines in the developed regions"

Major players operating in the U.S. mobile cardiac telemetry systems market are Medtronic, Philips, Medicomp Inc., Siemens and others, generating maximum revenue share. Players are developing with advanced monitoring expertise along with integrated solutions. Partnerships with small scale service providers, acquisitions, and improved R&D on top medical technology will invent the development of mobile cardiac telemetry systems market in the emerging nations shortly.

Key Industry Developments

In March 2019, VirtuOx (home respiratory diagnostic provider) launched a new service named CardioCHECK to diagnose cardiac arrhythmias.

Biotricity Inc. (medical diagnostic and healthcare technology company) received its 510(k) clearance for its Bioflux device with the U.S. FDA.

Historical & Forecast Period:

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Mobile Cardiac Telemetry Systems market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report

Micro and macro environment factors that are currently influencing the Mobile Cardiac Telemetry Systems market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

ATTRIBUTE DETAILS

Research Period 2020-2030

Base Year 2021

Forecast Period 2022-2030

Historical Year 2020

Unit USD Million

Segmentation

Product

Lead Based

Patch Based

End-user

Hospitals

Clinics

Ambulatory Surgical Centers

Region Segment (2020-2030; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

Pre COVID-19 situation

Post COVID-19 situation

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Mobile Cardiac Telemetry Systems market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2030.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Mobile Cardiac Telemetry Systems market?

Which is the largest regional market for Mobile Cardiac Telemetry Systems market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Mobile Cardiac Telemetry Systems market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Mobile Cardiac Telemetry Systems market worldwide?

Table of Contents

1. Preface

• 1.1. Report Description
  • 1.1.1. Purpose of the Report
  • 1.1.2. Target Audience
  • 1.1.3. Key Offerings
• 1.2. Market Segmentation
• 1.3. Research Methodology
  • 1.3.1. Phase I - Secondary Research
  • 1.3.2. Phase II - Primary Research
  • 1.3.3. Phase III - Expert Panel Review
  • 1.3.4. Assumptions
  • 1.3.5. Approach Adopted

2. Executive Summary

• 2.1. Market Snapshot: Global Mobile Cardiac Telemetry Systems Market
• 2.2. Global Mobile Cardiac Telemetry Systems Market, By Product, 2021 (US$ Million)
• 2.3. Global Mobile Cardiac Telemetry Systems Market, By End-user, 2021 (US$ Million)
• 2.4. Global Mobile Cardiac Telemetry Systems Market, By Geography, 2021 (US$ Million)
• 2.5. Impact of Covid 19
• 2.6. Attractive Investment Proposition by Geography, 2021
• 2.7. Competitive Analysis
  • 2.7.1. Market Positioning of Key Mobile Cardiac Telemetry Systems Market Vendors
  • 2.7.2. Strategies Adopted by Mobile Cardiac Telemetry Systems Market Vendors
  • 2.7.3. Key Industry Strategies

3. Mobile Cardiac Telemetry Systems Market: Business Outlook & Market Dynamics

• 3.1. Introduction
• 3.2. Global Mobile Cardiac Telemetry Systems Market Value, 2020 - 2030, (US$ Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers
  • 3.3.2. Market Restraints
  • 3.3.3. Key Challenges
  • 3.3.4. Key Opportunities
• 3.4. Impact Analysis of Drivers and Restraints
• 3.5. See-Saw Analysis
• 3.6. Porter's Five Force Model
  • 3.6.1. Supplier Power
  • 3.6.2. Buyer Power
  • 3.6.3. Threat Of Substitutes
  • 3.6.4. Threat Of New Entrants
  • 3.6.5. Competitive Rivalry
• 3.7. PESTEL Analysis
  • 3.7.1. Political Landscape
  • 3.7.2. Economic Landscape
  • 3.7.3. Technology Landscape
  • 3.7.4. Legal Landscape
  • 3.7.5. Social Landscape

4. Mobile Cardiac Telemetry Systems Market: By Product, 2020-2030, USD (Million)

• 4.1. Market Overview
• 4.2. Growth & Revenue Analysis: 2021 Versus 2030
• 4.3. Market Segmentation
  • 4.3.1. Lead Based
  • 4.3.2. Patch Based

5. Mobile Cardiac Telemetry Systems Market: By End-user, 2020-2030, USD (Million)

• 5.1. Market Overview
• 5.2. Growth & Revenue Analysis: 2021 Versus 2030
• 5.3. Market Segmentation
  • 5.3.1. Hospitals
  • 5.3.2. Clinics
  • 5.3.3. Ambulatory Surgical Centers

6. North America Mobile Cardiac Telemetry Systems Market, 2020-2030, USD (Million)

• 6.1. Market Overview
• 6.2. Mobile Cardiac Telemetry Systems Market: By Product, 2020-2030, USD (Million)
• 6.3. Mobile Cardiac Telemetry Systems Market: By End-user, 2020-2030, USD (Million)
• 6.4.Mobile Cardiac Telemetry Systems Market: By Region, 2020-2030, USD (Million)
  • 6.4.1.North America
    • 6.4.1.1. U.S.
    • 6.4.1.2. Canada
    • 6.4.1.3. Rest of North America

7. UK and European Union Mobile Cardiac Telemetry Systems Market, 2020-2030, USD (Million)

• 7.1. Market Overview
• 7.2. Mobile Cardiac Telemetry Systems Market: By Product, 2020-2030, USD (Million)
• 7.3. Mobile Cardiac Telemetry Systems Market: By End-user, 2020-2030, USD (Million)
• 7.4.Mobile Cardiac Telemetry Systems Market: By Region, 2020-2030, USD (Million)
  • 7.4.1.UK and European Union
    • 7.4.1.1. UK
    • 7.4.1.2. Germany
    • 7.4.1.3. Spain
    • 7.4.1.4. Italy
    • 7.4.1.5. France
    • 7.4.1.6. Rest of Europe

8. Asia Pacific Mobile Cardiac Telemetry Systems Market, 2020-2030, USD (Million)

• 8.1. Market Overview
• 8.2. Mobile Cardiac Telemetry Systems Market: By Product, 2020-2030, USD (Million)
• 8.3. Mobile Cardiac Telemetry Systems Market: By End-user, 2020-2030, USD (Million)
• 8.4.Mobile Cardiac Telemetry Systems Market: By Region, 2020-2030, USD (Million)
  • 8.4.1.Asia Pacific
    • 8.4.1.1. China
    • 8.4.1.2. Japan
    • 8.4.1.3. India
    • 8.4.1.4. Australia
    • 8.4.1.5. South Korea
    • 8.4.1.6. Rest of Asia Pacific

9. Latin America Mobile Cardiac Telemetry Systems Market, 2020-2030, USD (Million)

• 9.1. Market Overview
• 9.2. Mobile Cardiac Telemetry Systems Market: By Product, 2020-2030, USD (Million)
• 9.3. Mobile Cardiac Telemetry Systems Market: By End-user, 2020-2030, USD (Million)
• 9.4.Mobile Cardiac Telemetry Systems Market: By Region, 2020-2030, USD (Million)
  • 9.4.1.Latin America
    • 9.4.1.1. Brazil
    • 9.4.1.2. Mexico
    • 9.4.1.3. Rest of Latin America

10. Middle East and Africa Mobile Cardiac Telemetry Systems Market, 2020-2030, USD (Million)

• 10.1. Market Overview
• 10.2. Mobile Cardiac Telemetry Systems Market: By Product, 2020-2030, USD (Million)
• 10.3. Mobile Cardiac Telemetry Systems Market: By End-user, 2020-2030, USD (Million)
• 10.4.Mobile Cardiac Telemetry Systems Market: By Region, 2020-2030, USD (Million)
  • 10.4.1.Middle East and Africa
    • 10.4.1.1. GCC
    • 10.4.1.2. Africa
    • 10.4.1.3. Rest of Middle East and Africa

11. Company Profile

• 11.1. Medtronic Plc
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Portfolio
  • 11.1.4. Strategic Initiatives
• 11.2. Medicomp Inc.
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Portfolio
  • 11.2.4. Strategic Initiatives
• 11.3. BioTelemetry Inc.
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Portfolio
  • 11.3.4. Strategic Initiatives
• 11.4. ZOLL Medical Corporation
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Portfolio
  • 11.4.4. Strategic Initiatives
• 11.5. Welch Allyn
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Portfolio
  • 11.5.4. Strategic Initiatives
• 11.6. ScottCare
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Portfolio
  • 11.6.4. Strategic Initiatives
• 11.7. Siemens Healthcare Pvt. Ltd
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Portfolio
  • 11.7.4. Strategic Initiatives
• 11.8. Biotricity Inc.
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Portfolio
  • 11.8.4. Strategic Initiatives
• 11.9. Preventice Solutions
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Portfolio
  • 11.9.4. Strategic Initiatives
• 11.10. Telerhythmics LLC.
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Portfolio
  • 11.10.4. Strategic Initiatives
• 11.11. Applied Cardiac Systems Inc.
  • 11.11.1. Company Overview
  • 11.11.2. Financial Performance
  • 11.11.3. Product Portfolio
  • 11.11.4. Strategic Initiatives
• 11.12. Philips Benelux
  • 11.12.1. Company Overview
  • 11.12.2. Financial Performance
  • 11.12.3. Product Portfolio
  • 11.12.4. Strategic Initiatives

List of Tables

• TABLE 1 Global Mobile Cardiac Telemetry Systems Market By Product, 2020-2030, USD (Million)
• TABLE 2 Global Mobile Cardiac Telemetry Systems Market By End-user, 2020-2030, USD (Million)
• TABLE 3 North America Mobile Cardiac Telemetry Systems Market By Product, 2020-2030, USD (Million)
• TABLE 4 North America Mobile Cardiac Telemetry Systems Market By End-user, 2020-2030, USD (Million)
• TABLE 5 UK and European Union Mobile Cardiac Telemetry Systems Market By Product, 2020-2030, USD (Million)
• TABLE 6 UK and European Union Mobile Cardiac Telemetry Systems Market By End-user, 2020-2030, USD (Million)
• TABLE 7 Asia Pacific Mobile Cardiac Telemetry Systems Market By Product, 2020-2030, USD (Million)
• TABLE 8 Asia Pacific Mobile Cardiac Telemetry Systems Market By End-user, 2020-2030, USD (Million)
• TABLE 9 Latin America Mobile Cardiac Telemetry Systems Market By Product, 2020-2030, USD (Million)
• TABLE 10 Latin America Mobile Cardiac Telemetry Systems Market By End-user, 2020-2030, USD (Million)
• TABLE 11 Middle East and Africa Mobile Cardiac Telemetry Systems Market By Product, 2020-2030, USD (Million)
• TABLE 12 Middle East and Africa Mobile Cardiac Telemetry Systems Market By End-user, 2020-2030, USD (Million)

List of Figures

• FIG. 1 Global Mobile Cardiac Telemetry Systems Market: Market Coverage
• FIG. 2 Research Methodology and Data Sources
• FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
• FIG. 4 Global Mobile Cardiac Telemetry Systems Market: Quality Assurance
• FIG. 5 Global Mobile Cardiac Telemetry Systems Market, By Product, 2021
• FIG. 6 Global Mobile Cardiac Telemetry Systems Market, By End-user, 2021
• FIG. 7 Global Mobile Cardiac Telemetry Systems Market, By Geography, 2021
• FIG. 8 Global Mobile Cardiac Telemetry Systems Market, By Product, 2021 Vs 2030, %
• FIG. 9 Global Mobile Cardiac Telemetry Systems Market, By End-user, 2021 Vs 2030, %
• FIG. 10 U.S. Mobile Cardiac Telemetry Systems Market (US$ Million), 2020 - 2030
• FIG. 11 Canada Mobile Cardiac Telemetry Systems Market (US$ Million), 2020 - 2030
• FIG. 12 Rest of North America Mobile Cardiac Telemetry Systems Market (US$ Million), 2020 - 2030
• FIG. 13 UK Mobile Cardiac Telemetry Systems Market (US$ Million), 2020 - 2030
• FIG. 14 Germany Mobile Cardiac Telemetry Systems Market (US$ Million), 2020 - 2030
• FIG. 15 Spain Mobile Cardiac Telemetry Systems Market (US$ Million), 2020 - 2030
• FIG. 16 Italy Mobile Cardiac Telemetry Systems Market (US$ Million), 2020 - 2030
• FIG. 17 France Mobile Cardiac Telemetry Systems Market (US$ Million), 2020 - 2030
• FIG. 18 Rest of Europe Mobile Cardiac Telemetry Systems Market (US$ Million), 2020 - 2030
• FIG. 19 China Mobile Cardiac Telemetry Systems Market (US$ Million), 2020 - 2030
• FIG. 20 Japan Mobile Cardiac Telemetry Systems Market (US$ Million), 2020 - 2030
• FIG. 21 India Mobile Cardiac Telemetry Systems Market (US$ Million), 2020 - 2030
• FIG. 22 Australia Mobile Cardiac Telemetry Systems Market (US$ Million), 2020 - 2030
• FIG. 23 South Korea Mobile Cardiac Telemetry Systems Market (US$ Million), 2020 - 2030
• FIG. 24 Rest of Asia Mobile Cardiac Telemetry Systems Market (US$ Million), 2020 - 2030
• FIG. 25 Brazil Mobile Cardiac Telemetry Systems Market (US$ Million), 2020 - 2030
• FIG. 26 Mexico Mobile Cardiac Telemetry Systems Market (US$ Million), 2020 - 2030
• FIG. 27 Rest of Latin America Mobile Cardiac Telemetry Systems Market (US$ Million), 2020 - 2030
• FIG. 28 GCC Mobile Cardiac Telemetry Systems Market (US$ Million), 2020 - 2030
• FIG. 29 Africa Mobile Cardiac Telemetry Systems Market (US$ Million), 2020 - 2030
• FIG. 30 Rest of Middle East and Africa Mobile Cardiac Telemetry Systems Market (US$ Million), 2020 - 2030